Condition
Portal Vein Thrombosis clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Portal Vein Thrombosis clinical trials that are recruiting, at sites in 4 countries (most in China (4), Germany (1), Egypt (1)). By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 4Countries
Newest Portal Vein Thrombosis clinical trials
All recruiting trials (7)
-
Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis
This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.
-
Factors that affect reopening of blocked portal veins in people with cirrhosis and gastroesophageal varices
This project looks at past records and follow-up to see which factors are linked with reopening (recanalization) of blocked portal veins in people who have cirrhosis and endoscopy-confirmed gastroesophageal varices.
-
Apixaban for portal vein clots that appear more than a year after laparoscopic splenectomy
This trial tests whether taking apixaban twice daily can treat portal vein blood clots that develop more than a year after laparoscopic splenectomy in people with cirrhosis.
-
Apixaban for portal vein thrombosis occurring more than one year after laparoscopic splenectomy and azygoportal disconnection
This trial will try whether taking apixaban 2.5 mg twice daily can treat portal vein clots that appear more than a year after laparoscopic splenectomy and azygoportal disconnection in people with cirrhosis.
-
Comparing blood thinners for people with cirrhosis and portal vein clots
This will try enoxaparin, warfarin, or apixaban in people with cirrhosis and portal vein thrombosis (with or without liver cancer) to see which controls the clot and is safest.
-
Investigating how portal vein thrombosis affects liver transplantation outcomes
This study looks at how having portal vein thrombosis affects the success of liver transplants to help doctors understand the risks and outcomes better.
-
Registry for patients undergoing TIPS implantation for portal hypertension
This study is collecting information from patients with serious portal hypertension who are getting a TIPS procedure to see how well it works and what complications might happen afterward.
Related topics
Quick answers
How many Portal Vein Thrombosis clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (4 trials), Germany (1 trial), Egypt (1 trial), Pakistan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.